ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681637 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681637; 2) Community: the network communities that were significantly associated with the response to NSC 681637; 3) Molecule: the relationships between components within communities and NSC 681637; 4) MDR: the compounds that were significantly associated with the NSC 681637.

NSC Compound Enrichment Correlation
NSC 720447 Null 0.0228801759885687 -0.156588
NSC 726267 Null 0.0228801759885687 0.31054148
NSC 740 Methotrexate 0.0228801759885687 0.56045265
NSC 748712 Null 0.0228801759885687 0.28863278
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0228801759885687 0.073813438
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0238174255956144 0.16334236
NSC 717189 Null 0.0238174255956146 -0.065368787
NSC 132313 Dianhydrogalactitol 0.0238174255956147 0.79592925
NSC 144126 Null 0.0238174255956147 -0.077916166
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0238174255956147 0.33199179
Total:72  Current:32    [First] [Prev] [Next] [Last]